Response assessment for HCC patients treated with repeated TACE: The optimal time-point is still an open issue
- PMID: 26256436
- DOI: 10.1016/j.jhep.2015.07.031
Response assessment for HCC patients treated with repeated TACE: The optimal time-point is still an open issue
Comment in
-
Reply to "Response assessment for HCC patients treated with repeated TACE: The optimal time-point is still an open issue".J Hepatol. 2015 Dec;63(6):1532. doi: 10.1016/j.jhep.2015.09.003. Epub 2015 Sep 12. J Hepatol. 2015. PMID: 26375243 No abstract available.
Comment on
-
Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma.J Hepatol. 2015 Jun;62(6):1304-10. doi: 10.1016/j.jhep.2015.01.022. Epub 2015 Jan 29. J Hepatol. 2015. PMID: 25637785
Publication types
MeSH terms
LinkOut - more resources
Medical
Miscellaneous